Indicated in adults and pediatric patients (3 months and older) for:
- Empirical therapy for presumed fungal infections in febrile, neutropenic patients.
- Treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. Has not been studied in endocarditis, ostemyelitis, and meningitis due to Candida.
- Treatment of esophageal candidiasis.
- Treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin B, lipid formulations of amphotericin B, and/or itraconazole). Has not been studied as initial therapy for invasive aspergillosis.
